Our overall objective is to develop collaboration between European and Chinese Specialist in Biomedical Research and\/or Chinese Herbal Medicines (CHM) in order to:<\/p>\n
Interaction with other WPs:<\/p>\n
WP5 is actively collaborating with WP4 (in vitro studies), WP3 (toxicology) and WP6 (clinical studies). In fact, participants in our WP5 are also participants in other WPs, including WP3 and WP4.<\/p>\n
Potential WP impact:<\/p>\n
WP4 and WP5 are defined as the core value of the project, since the therapeutic values of CHM should be evaluates using in vivo and in vitro settings. Moreover, in coordination with WP6, the pharmacology of CHM in animal models and patient will be discussed. Guidelines proposed by WP5 will significantly promote the understanding of TCM. Drugs should be first tested in animal models before moving on clinical trials. Diagnosis in patients as well as in animal models in a TCM way \u201cZhenghou\u201d might be difficult but it will be critical for TCM efficacy evaluation. WP5 will deliver guidelines for non conventional diagnosis methods in animal models. Functional genomic studies to be applied to animal models of TCM will be another novel and relevant deliverable for our WP.<\/p>\n
Prof. Francisco Javier Lucio Caza\u00f1a (WP5 Coordinator, University of Alcala, Spain)<\/p>\n
Dr. Maria Laura Garcia Bermejo (WP4 Assistant Coordinator, University Hospital Ram\u00f3n y Cajal, Spain)<\/p>\n
Prof. Bruce Hendry (King\u2019s College London, UK)<\/p>\n
Dr. Qihe Xu (King\u2019s College London, UK)<\/p>\n
Prof. Peter Hylands (King\u2019s College London, UK)<\/p>\n
Dr. Joelle Nortier (Universit\u00e9 Libre de Bruxelles, Belgium)<\/p>\n
Prof. Jifeng Wang (Beijing University of Chinese Medicine)<\/p>\n
Ms. Noelia Tejedor (University of Alcala, Spain)<\/p>\n
Dr. Ana Bel\u00e9n Fern\u00e1ndez Mart\u00ednez (University of Alcala, Spain)<\/p>\n
Prof. Sue Watson (WP5 Deputy Coordinator,\u00a0 University of Nottingham, UK)<\/p>\n
Prof. Ping Li (China-Japan Friendship Hospital, China)<\/p>\n
Prof. Liping Zhao (Shanghai Jiaotong University, China)<\/p>\n
Prof. Xiaodong Cheng (Shanghai University of Traditional Chinese Medicine, China)<\/p>\n
Dr. William Weiguo Jia (Shanghai Innovation Research Center of Traditional Medicine, China)<\/p>\n
Dr. Huige Li (Johannes Gutenberg University, Germany)<\/p>\n
Ms. Gemma Olmos Centenera (University of Alcal\u00e1, Spain)<\/p>\n
Prof. Y. James Kang (University of Louisville, USA)<\/p>\n
Dr. Rajendra Kumari (University of Nottingham, UK)<\/p>\n
Prof. Zuguang Ye (China Academy of Chinese Medical Sciences, China)<\/p>\n
Dr. Xuebin Dong (King\u2019s College London, UK)<\/p>\n
Dr. Maria Laura Garcia Bermejo<\/p>\n
WP5 Assistant Coordinator<\/p>\n
Department of Pathology<\/p>\n
University Hospital Ram\u00f3n y Cajal<\/p>\n
Carretera de Colmenar, km 9,100<\/p>\n
28034 Madrid<\/p>\n
Spain<\/p>\n
Tel:\u00a0 +34 91 336 80 75<\/p>\n
Fax: +34 91 336 90 16<\/p>\n